Annual EBITDA
-$69.57 M
+$11.80 M+14.51%
December 31, 2023
Summary
- As of February 7, 2025, SOPH annual EBITDA is -$69.57 million, with the most recent change of +$11.80 million (+14.51%) on December 31, 2023.
- During the last 3 years, SOPH annual EBITDA has fallen by -$31.58 million (-83.11%).
- SOPH annual EBITDA is now -126.32% below its all-time high of -$30.74 million, reached on December 31, 2019.
Performance
SOPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.15 M
-$182.00 K-1.40%
September 30, 2024
Summary
- As of February 7, 2025, SOPH quarterly EBITDA is -$13.15 million, with the most recent change of -$182.00 thousand (-1.40%) on September 30, 2024.
- Over the past year, SOPH quarterly EBITDA has increased by +$1.19 million (+8.32%).
- SOPH quarterly EBITDA is now -102.53% below its all-time high of -$6.49 million, reached on June 1, 2020.
Performance
SOPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$62.86 M
+$1.19 M+1.86%
September 30, 2024
Summary
- As of February 7, 2025, SOPH TTM EBITDA is -$62.86 million, with the most recent change of +$1.19 million (+1.86%) on September 30, 2024.
- Over the past year, SOPH TTM EBITDA has dropped by -$683.00 thousand (-1.10%).
- SOPH TTM EBITDA is now -595.07% below its all-time high of -$9.04 million, reached on March 31, 2020.
Performance
SOPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SOPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.5% | +8.3% | -1.1% |
| 3 y3 years | -83.1% | +8.3% | -1.1% |
| 5 y5 years | - | +8.3% | -1.1% |
SOPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.5% | +14.5% | -3.9% | +44.8% | -1.1% | +30.0% |
| 5 y | 5-year | -126.3% | +14.5% | -102.5% | +44.8% | -595.1% | +30.0% |
| alltime | all time | -126.3% | +14.5% | -102.5% | +44.8% | -595.1% | +30.0% |
SOPHiA GENETICS SA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.15 M(+1.4%) | -$62.86 M(-1.9%) |
| Jun 2024 | - | -$12.97 M(-22.3%) | -$64.06 M(-7.0%) |
| Mar 2024 | - | -$16.70 M(-16.7%) | -$68.87 M(-1.0%) |
| Dec 2023 | -$69.57 M(-14.5%) | -$20.05 M(+39.8%) | -$69.57 M(+11.9%) |
| Sep 2023 | - | -$14.34 M(-19.3%) | -$62.18 M(-11.2%) |
| Jun 2023 | - | -$17.78 M(+2.2%) | -$70.03 M(-6.6%) |
| Mar 2023 | - | -$17.40 M(+37.5%) | -$74.94 M(-7.9%) |
| Dec 2022 | -$81.38 M | -$12.66 M(-43.0%) | -$81.38 M(-9.4%) |
| Sep 2022 | - | -$22.19 M(-2.2%) | -$89.86 M(+3.1%) |
| Jun 2022 | - | -$22.69 M(-4.8%) | -$87.17 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.83 M(+12.7%) | -$79.70 M(+15.1%) |
| Dec 2021 | -$69.24 M(+82.2%) | -$21.14 M(+8.4%) | -$69.24 M(+12.1%) |
| Sep 2021 | - | -$19.50 M(+28.1%) | -$61.74 M(+20.9%) |
| Jun 2021 | - | -$15.22 M(+13.8%) | -$51.05 M(+20.6%) |
| Mar 2021 | - | -$13.37 M(-2.0%) | -$42.33 M(+11.4%) |
| Dec 2020 | -$37.99 M(+23.6%) | - | - |
| Dec 2020 | - | -$13.64 M(+54.7%) | -$37.99 M(+56.0%) |
| Sep 2020 | - | -$8.82 M(+35.8%) | -$24.35 M(+56.7%) |
| Jun 2020 | - | -$6.49 M(-28.2%) | -$15.54 M(+71.8%) |
| Mar 2020 | - | -$9.04 M | -$9.04 M |
| Dec 2019 | -$30.74 M | - | - |
FAQ
- What is SOPHiA GENETICS SA annual EBITDA?
- What is the all time high annual EBITDA for SOPHiA GENETICS SA?
- What is SOPHiA GENETICS SA annual EBITDA year-on-year change?
- What is SOPHiA GENETICS SA quarterly EBITDA?
- What is the all time high quarterly EBITDA for SOPHiA GENETICS SA?
- What is SOPHiA GENETICS SA quarterly EBITDA year-on-year change?
- What is SOPHiA GENETICS SA TTM EBITDA?
- What is the all time high TTM EBITDA for SOPHiA GENETICS SA?
- What is SOPHiA GENETICS SA TTM EBITDA year-on-year change?
What is SOPHiA GENETICS SA annual EBITDA?
The current annual EBITDA of SOPH is -$69.57 M
What is the all time high annual EBITDA for SOPHiA GENETICS SA?
SOPHiA GENETICS SA all-time high annual EBITDA is -$30.74 M
What is SOPHiA GENETICS SA annual EBITDA year-on-year change?
Over the past year, SOPH annual EBITDA has changed by +$11.80 M (+14.51%)
What is SOPHiA GENETICS SA quarterly EBITDA?
The current quarterly EBITDA of SOPH is -$13.15 M
What is the all time high quarterly EBITDA for SOPHiA GENETICS SA?
SOPHiA GENETICS SA all-time high quarterly EBITDA is -$6.49 M
What is SOPHiA GENETICS SA quarterly EBITDA year-on-year change?
Over the past year, SOPH quarterly EBITDA has changed by +$1.19 M (+8.32%)
What is SOPHiA GENETICS SA TTM EBITDA?
The current TTM EBITDA of SOPH is -$62.86 M
What is the all time high TTM EBITDA for SOPHiA GENETICS SA?
SOPHiA GENETICS SA all-time high TTM EBITDA is -$9.04 M
What is SOPHiA GENETICS SA TTM EBITDA year-on-year change?
Over the past year, SOPH TTM EBITDA has changed by -$683.00 K (-1.10%)